New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 2, 2013
07:55 EDTUTHRUnited Therapeutics price target raised to $110 from $85 at Argus
Argus increased its price target on United Therapeutics as the firm believes that the company reported solid Q3 results and should benefit from launches of its Remodulin treatment in overseas markets. The firm keeps a Buy rating on the stock.
News For UTHR From The Last 14 Days
Check below for free stories on UTHR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2014
07:24 EDTUTHRInternational Society for Heart & Lung Transplantation to hold annual meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use